Search research articles
Contact Us
Filters
Showing results (171-180 of 274) with videos related to
Page
of 28
Sort By:
Frontiers in Immunology
|
December 19, 2022
Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma
Junqiang Lv, Hao Sun, Lixin Gong, et al.
Oncotarget
|
December 13, 2017
Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region
Shuhua Yi, Yuting Yan, Wenjie Xiong, et al.
Leukemia
|
March 30, 2026
Prognostic significance of clinical risk models and genomic alterations in Waldenström macroglobulinemia before or after the BTK inhibitor era
Yuting Yan, Weihao Chen, Ying Yu, et al.
Blood Science (Baltimore, Md.)
|
January 19, 2024
Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia
Ying Yu, Wenjie Xiong, Tingyu Wang, et al.
Leukemia & Lymphoma
|
June 21, 2012
Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains
Yan Xu, Weiwei Sui, Shuhui Deng, et al.
Frontiers in Immunology
|
July 24, 2023
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China
Yuting Yan, Rui Lv, Tingyu Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
May 17, 2011
[The significances of 13q14 deletion for development and prognosis of multiple myeloma]
Qian Li, Gang An, Cheng-wen Li, et al.
Haematologica
|
February 12, 2026
Single-cell dissection of plasma cell clonal evolution to smoldering multiple myeloma after CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia
Heye Yu, Guangji Zhang, Benfa Gong, et al.
Communications Biology
|
March 11, 2026
Deep learning-based in silico labeling for analyzing morphological features of MSCs to predict immunomodulatory capacity
Zhiyu Liu, Gang An, Xiao Liang, et al.
Zhonghua Yi Xue Za Zhi
|
February 11, 2012
[Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders]
Ke-Shu Zhou, Zhen Yu, Shu-Hua Yi, et al.
Page
of 28
Search research articles
Search
Showing results (171-180 of 274) with videos related to
Sort By:
Page
of 28
Frontiers in Immunology
|
December 19, 2022
Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma
Junqiang Lv, Hao Sun, Lixin Gong, et al.
Oncotarget
|
December 13, 2017
Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region
Shuhua Yi, Yuting Yan, Wenjie Xiong, et al.
Leukemia
|
March 30, 2026
Prognostic significance of clinical risk models and genomic alterations in Waldenström macroglobulinemia before or after the BTK inhibitor era
Yuting Yan, Weihao Chen, Ying Yu, et al.
Blood Science (Baltimore, Md.)
|
January 19, 2024
Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia
Ying Yu, Wenjie Xiong, Tingyu Wang, et al.
Leukemia & Lymphoma
|
June 21, 2012
Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains
Yan Xu, Weiwei Sui, Shuhui Deng, et al.
Frontiers in Immunology
|
July 24, 2023
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China
Yuting Yan, Rui Lv, Tingyu Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
May 17, 2011
[The significances of 13q14 deletion for development and prognosis of multiple myeloma]
Qian Li, Gang An, Cheng-wen Li, et al.
Haematologica
|
February 12, 2026
Single-cell dissection of plasma cell clonal evolution to smoldering multiple myeloma after CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia
Heye Yu, Guangji Zhang, Benfa Gong, et al.
Communications Biology
|
March 11, 2026
Deep learning-based in silico labeling for analyzing morphological features of MSCs to predict immunomodulatory capacity
Zhiyu Liu, Gang An, Xiao Liang, et al.
Zhonghua Yi Xue Za Zhi
|
February 11, 2012
[Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders]
Ke-Shu Zhou, Zhen Yu, Shu-Hua Yi, et al.
Page
of 28